# HIV DART and Emerging Viruses: Frontiers in Drug Development and Antiretroviral Therapies

> **NIH NIH R13** · EMORY UNIVERSITY · 2022 · $1

## Abstract

Abstract/Project Summary
 Thanks to advances in antiretroviral therapy, the face of HIV and AIDS has been gradually
and meaningfully transformed from a deadly disease, into a chronic condition that is managed
with careful adherence to life-long treatment regimens. The need for improved drugs, with fewer
side-effects, improved adherence and more favorable pharmacokinetics increases as the number
of infected individuals on long-term therapy continues to rise. Importantly, the quest for an HIV
cure continues to gain momentum as we learn more about viral reservoirs and mechanisms of
viral persistence. HIV DART and Emerging Viruses is a biennial conference for physicians,
clinicians, nurses, scientists and clinical researchers that will focus on the latest discoveries in
these areas.
 Specific Aims: 1. Gather cross-disciplinary professionals such as clinicians, health care
workers, researchers and basic scientists together in an interactive workshop setting to share
and discuss the latest developments in the field of HIV and emerging viruses; 2. Facilitate the
neutral and balanced exchange of scientific knowledge with regard to antiviral drug
development, vaccine development, and recent progress in curative strategies; 3. Enhance the
training of young scientists such as graduate students and post-doctoral fellows and provide
increased opportunities for underrepresented scientists and health care workers through
attendee scholarships. Educational Objectives: 1. Identify novel therapeutic agents and viral
targets for HIV, retroviruses and other emerging viruses; 2. Understand HIV reservoirs and viral
persistence; 3. Discuss novel remission, cure, and eradication strategies for HIV; 4. Discuss
inflammation in the context of HIV infection, neuroAIDS and AIDS in geriatric and pediatric
populations; 5. Understand drug metabolism and pharmacology and discuss improved
formulations; 6. Discuss treatment access, treatment as prevention and the role of microbicides;
7. Discuss HIV treatment in the context of co-infection with Hepatitis B or hepatitis C virus; 8.
Discuss recent advances in vaccine development and systems serology; 9. Discuss recent
scientific discoveries with regard to emerging viral threats such as Ebola, Zika, chikungunya,
dengue and yellow fever. Design & Methods: HIV DART and Emerging Viruses will take place in
the United States of America over a 2.5 days period, at a location that is easily accessed by both
national and international delegates. The program will include plenary lectures, oral abstract
presentations, discussion panels and a debate. This ACCME-accredited program will provide
ample time for formal and informal networking and discussion amongst the delegates during the
poster session and meal breaks.

## Key facts

- **NIH application ID:** 10294240
- **Project number:** 5R13AI143393-04
- **Recipient organization:** EMORY UNIVERSITY
- **Principal Investigator:** Raymond Felix Schinazi
- **Activity code:** R13 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $1
- **Award type:** 5
- **Project period:** 2018-11-13 → 2023-10-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10294240

## Citation

> US National Institutes of Health, RePORTER application 10294240, HIV DART and Emerging Viruses: Frontiers in Drug Development and Antiretroviral Therapies (5R13AI143393-04). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10294240. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*